The Bartlett & Co. LLC Boosts Position in CVS Health Corp (CVS)

The Bartlett & Co. LLC Boosts Position in CVS Health Corp (CVS)

Other hedge funds have also modified their holdings of the company. Penobscot Investment Management Company Inc. increased its stake in shares of CVS Health Corp by 3.6% in the first quarter. Penobscot Investment Management Company Inc. now owns 64,764 shares of the pharmacy operator’s stock valued at $5,084,000 after buying an additional 2,250 shares in the last quarter. Founders Financial Securities LLC acquired a new stake in shares of CVS Health Corp during the first quarter valued at approximately $945,000. River Road Asset Management LLC increased its stake in shares of CVS Health Corp by 514.9% in the first quarter. River Road Asset Management LLC now owns 634,824 shares of the pharmacy operator’s stock valued at $49,834,000 after buying an additional 531,586 shares in the last quarter. Sawgrass Asset Management LLC increased its stake in shares of CVS Health Corp by 22.2% in the first quarter. Sawgrass Asset Management LLC now owns 26,978 shares of the pharmacy operator’s stock valued at $2,118,000 after buying an additional 4,905 shares in the last quarter. Finally, Adviser Investments LLC increased its stake in shares of CVS Health Corp by 1,759.5% in the first quarter. Adviser Investments LLC now owns 48,198 shares of the pharmacy operator’s stock valued at $3,784,000 after buying an additional 45,606 shares in the last quarter. Institutional investors and hedge funds own 81.29% of the company’s stock.

Bartlett & Co. LLC raised its stake in shares of CVS Health Corp (NYSE:CVS) by 0.9% during the first quarter, Holdings Channel reports. The institutional investor owned 473,241 shares of the pharmacy operator’s stock after buying an additional 4,318 shares during the period. CVS Health Corp accounts for 1.7% of Bartlett & Co. LLC’s portfolio, making the stock its 18th largest position. Bartlett & Co. LLC’s holdings in CVS Health Corp were worth $37,149,000 at the end of the most recent quarter.

Shares of CVS Health Corp (NYSE:CVS) opened at 79.05 on Monday. CVS Health Corp has a 52 week low of $69.30 and a 52 week high of $98.67. The stock has a market cap of $80.54 billion, a PE ratio of 16.49 and a beta of 0.85. The company’s 50-day moving average is $79.23 and its 200 day moving average is $79.01.

CVS Health Corp (NYSE:CVS) last posted its quarterly earnings data on Tuesday, May 2nd. The pharmacy operator reported $1.17 earnings per share for the quarter, beating analysts’ consensus estimates of $1.10 by $0.07. The business had revenue of $44.51 billion during the quarter, compared to analyst estimates of $44.20 billion. CVS Health Corp had a net margin of 2.16% and a return on equity of 10.97%. The company’s revenue was up 3.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.18 earnings per share. Analysts forecast that CVS Health Corp will post $5.87 earnings per share for the current fiscal year.

CVS has been the topic of several research analyst reports. Guggenheim reissued a “buy” rating and set a $90.00 price target on shares of CVS Health Corp in a report on Monday, February 6th. Atlantic Securities cut CVS Health Corp from an “overweight” rating to a “neutral” rating and set a $84.00 price target on the stock. in a report on Monday, February 6th. Deutsche Bank AG reissued a “hold” rating and set a $88.00 price target on shares of CVS Health Corp in a report on Wednesday, February 8th. Evercore ISI lowered their price target on CVS Health Corp from $91.50 to $84.00 and set a “buy” rating on the stock in a report on Thursday, February 9th. Finally, Leerink Swann set a $90.00 price target on CVS Health Corp and gave the company a “buy” rating in a report on Saturday, February 11th. Eight equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $94.39.

In related news, EVP Eva C. Boratto sold 6,029 shares of the business’s stock in a transaction that occurred on Friday, March 17th. The shares were sold at an average price of $79.60, for a total value of $479,908.40. Following the completion of the sale, the executive vice president now directly owns 41,614 shares in the company, valued at $3,312,474.40. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Troyen A. Brennan sold 23,849 shares of the business’s stock in a transaction that occurred on Tuesday, March 21st. The shares were sold at an average price of $78.73, for a total transaction of $1,877,631.77. Following the completion of the sale, the executive vice president now owns 94,309 shares of the company’s stock, valued at $7,424,947.57. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 139,600 shares of company stock valued at $11,205,962. 0.58% of the stock is owned by insiders. CVS Health Corp Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “CVS”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS). Receive News & Ratings for CVS Health Corp Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CVS Health Corp and related companies with MarketBeat.com’s FREE daily email newsletter.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Related posts

Leave a Comment